Correction to: Acta neuropathol commun (2019) 7: 4

https://doi.org/10.1186/s40478-018-0654-6

In the original publication of this article [1], the funding acknowledgement for grant “Alzheimer Society Research Program (ASRP) from the Alzheimer Society of Canada” was missing. In this correction article the updated funding acknowledgement is shown. The missing funding acknowledgement has been indicated in bold.

The Dementia Research Centre is supported by Alzheimer’s Research UK, Brain Research Trust, and The Wolfson Foundation. This work was supported by the NIHR Queen Square Dementia Biomedical Research Unit and the NIHR UCL/H Biomedical Research Centre, the MRC UK GENFI grant and the Alzheimer’s Society.

IFH is funded by a research grant from Eli Lilly and Company, and the Engineering and Physical Sciences Research Council (EPSRC) UK (EP/N034864/1).

JMO’C is funded by UK Medical Research Council (MRC) Doctoral Training Grant Studentship (MR/J500422/1).

LC is funded by an unrestricted grant from OPTOS Plc. Ltd.

DM received a proportion of funding from EPSRC studentship from UCL’s Centre for Doctoral Training in Medical Imaging, and a proportion of funding from the Alzheimer Society of Canada through the Alzheimer Society Research Program (ASRP).

JDR is supported by an MRC Clinician Scientist Fellowship (MR/M008525/1) and has received funding from the NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH).

MFL receives funding from BBSRC/AstraZeneca Industrial Partnership Studentship (BB/E528979/1), the UK Regenerative Medicine Platform Safety Hub (MR/K026739/1), Eli Lilly and Company, and the EPSRC (EP/N034864/1).

IL receives funding from the Bill Brown Charitable Trust, Moorfields Eye Hospital Special Trustees and Mercer Fund from Fight for Sight.